FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1764-1772 June 7, 2001 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Editorial by Steinbrook, R. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Gottlieb, M. S. PubMed Citation

The disease now known as the acquired immunodeficiency syndrome, or AIDS, was first reported 20 years ago this week in the Morbidity and Mortality Weekly Report under the quiet title "Pneumocystis pneumonia — Los Angeles."¹ The description was not the lead article; that distinction went to a report of dengue infections in vacationers returning to the United States from the Caribbean.

Not even the most pessimistic reader could have anticipated the scope and scale the epidemic would assume two decades later. By December 2000, 21.8 million people worldwide had died of the disease, including more Americans (438,795) than died . . . [Full Text of this Article]

Early Years: Free Fall

Causation

Treatment

The Late 1980s: Slow Progress

The Mid-1990s: High Hopes

The Late 1990s: Global Crisis

The Blood Supply and AIDS Activism

Blood Banking

New Drugs and Disease-Related Activism

Conclusions

Source Information

From the Clinical Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York.

Address reprint requests to Dr. Sepkowitz at the Clinical Infectious Disease Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, or at sepkowik@mskcc.org.

References

This article has been cited by other articles:

• Sackoff, J. E., Hanna, D. B., Pfeiffer, M. R., Torian, L. V. (2006). Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.. ANN INTERN MED 145: 397-406 [Abstract] [Full Text]  
• Mounier, N., Spina, M., Gabarre, J., Raphael, M., Rizzardini, G., Golfier, J.-B., Vaccher, E., Carbone, A., Coiffier, B., Chichino, G., Bosly, A., Tirelli, U., Gisselbrecht, C., for the French-Italian cooperative group, (2006). AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 107: 3832-3840 [Abstract] [Full Text]  
• Zhang, Z., Fu, J., Zhao, Q., He, Y., Jin, L., Zhang, H., Yao, J., Zhang, L., Wang, F.-S. (2006). Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy. J. Immunol. 176: 5644-5651 [Abstract] [Full Text]  
• Omrani, A. S., Freedman, A. (2005). Prophylaxis of HIV infection. Br Med Bull 73-74: 93-105 [Abstract] [Full Text]  
• Uphold, C. R., Deloria-Knoll, M., Palella, F. J. Jr, Parada, J. P., Chmiel, J. S., Phan, L., Bennett, C. L. (2004). US Hospital Care for Patients With HIV Infection and Pneumonia: The Role of Public, Private, and Veterans Affairs Hospitals in the Early Highly Active Antiretroviral Therapy Era. Chest 125: 548-556 [Abstract] [Full Text]  
• Neuman de Vegvar, H. E., Amara, R. R., Steinman, L., Utz, P. J., Robinson, H. L., Robinson, W. H. (2003). Microarray Profiling of Antibody Responses against Simian-Human Immunodeficiency Virus: Postchallenge Convergence of Reactivities Independent of Host Histocompatibility Type and Vaccine Regimen. J. Virol. 77: 11125-11138 [Abstract] [Full Text]  
• Koh, Y., Nakata, H., Maeda, K., Ogata, H., Bilcer, G., Devasamudram, T., Kincaid, J. F., Boross, P., Wang, Y.-F., Tie, Y., Volarath, P., Gaddis, L., Harrison, R. W., Weber, I. T., Ghosh, A. K., Mitsuya, H. (2003). Novel bis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro. Antimicrob. Agents Chemother. 47: 3123-3129 [Abstract] [Full Text]  
• Scott, L. D. (2003). Research-Related Injury: Problems and Solutions. J Law Med Ethics 31: 419-428  
• Sandberg, J. K., Fast, N. M., Jordan, K. A., Furlan, S. N., Barbour, J. D., Fennelly, G., Dobroszycki, J., Spiegel, H. M. L., Wiznia, A., Rosenberg, M. G., Nixon, D. F. (2003). HIV-Specific CD8+ T Cell Function in Children with Vertically Acquired HIV-1 Infection Is Critically Influenced by Age and the State of the CD4+ T Cell Compartment. J. Immunol. 170: 4403-4410 [Abstract] [Full Text]  
• Uckun, F. M., Rajamohan, F., Pendergrass, S., Ozer, Z., Waurzyniak, B., Mao, C. (2003). Structure-Based Design and Engineering of a Nontoxic Recombinant Pokeweed Antiviral Protein with Potent Anti-Human Immunodeficiency Virus Activity. Antimicrob. Agents Chemother. 47: 1052-1061 [Abstract] [Full Text]  
• Watt, G., Burnouf, T. (2002). AIDS -- Past and Future. NEJM 346: 710-711 [Full Text]  
• Greene, K., Frey, L. R., Derlega, V. J. (2002). Interpersonalizing Aids: Attending to the Personal and Social Relationships of Individuals Living with Hiv and/or Aids. Journal of Social and Personal Relationships 19: 5-17 [Abstract]  
• Williamson, C. (2001). What does involving consumers in research mean?. QJM 94: 661-664 [Full Text]  
• Steinbrook, R., Drazen, J. M. (2001). AIDS -- Will the Next 20 Years Be Different?. NEJM 344: 1781-1782 [Full Text]  
• Gottlieb, M. S. (2001). AIDS -- Past and Future. NEJM 344: 1788-1791 [Full Text]